EditorialEditorial
Single-arm trials for domestic oncology drug approvals in China
Hong Zhang, Sen Liu, Chenghao Ge, Xiaozhen Liu, Yang Liu, Chen Yin, Yi Li, Jing An, Zhongtian Yan and Xiaoyuan Chen
Cancer Biology & Medicine November 2023, 20230360; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0360
Hong Zhang
1Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China
Sen Liu
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Chenghao Ge
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Xiaozhen Liu
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Yang Liu
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Chen Yin
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Yi Li
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Jing An
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Zhongtian Yan
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
Xiaoyuan Chen
2Tsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing 100084, China
3Office of Clinical Trial Institute, Beijing Tsinghua Changgung Hospital, Beijing 102218, China
References
- 1.↵
- Maomao C,
- He L,
- Dianqin S,
- Siyi H,
- Xinxin Y,
- Fan Y, et al.
- 2.↵
- Cheng X,
- Zhao W,
- Zhu M,
- Wang B,
- Wang X,
- Yang X, et al.
- 3.↵U.S. Food and Drug Administration. Guidance for industry: clinical trial considerations to support accelerated approval of oncology therapeutics. 2023. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-trial-considerations-support-accelerated-approval-oncology-therapeutics.
- 4.European Medicines Agency. Guideline on the scientific application and the practical arrangements necessary to implement Regulation (EC) No 507/2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004. 2006. Available from: https://www.ema.europa.eu/en/guideline-scientific-application-practical-arrangements-necessary-implement-regulation-ec-no-507.
- 5.↵Center for Drug Evaluation, National Medical Products Administration. Technical guidelines for the conditional approval of drugs. 2020. Available from: https://www.cde.org.cn/main/news/viewInfoCommon/d1716db06f90c3adf134de337373b22c.
- 6.↵
- Agrawal S,
- Arora S,
- Amiri-Kordestani L,
- de Claro RA,
- Fashoyin-Aje L,
- Gormley N, et al.
- 7.↵
- Luo X,
- Du X,
- Huang L,
- Guo Q,
- Lv X,
- Wang C, et al.
- 8.↵Center for Drug Evaluation, National Medical Products Administration. Technical guidelines on the applicability of single-arm clinical trials for use in support of oncology drug marketing applications. 2023. Available from: https://www.cde.org.cn/main/news/viewInfoCommon/9f0c25dee6ba6781af809b36cf682eb6.
- 9.↵National Medical Products Administration. Procedure for review and approval of applications for conditional marketing authorization (draft for solicitation of comments). 2023. Available from: https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20230825104212129.html.
- 10.↵U.S. Food and Drug Administration. Guidance for industry: considerations for the design and conduct of externally controlled trials for drug and biological products. 2023. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-design-and-conduct-externally-controlled-trials-drug-and-biological-products.
- 11.↵Oncologic Drugs Advisory Committee (ODAC) Meeting. 2022. FDA website. Accessed April 21, 2022. Available from: https://www.fda.gov/advisory-committees/oncologic-drugs-advisory-committee/2022-meeting-materials-oncologic-drugs-advisory-committee.
- 12.↵Center for Drug Evaluation, National Medical Products Administration. Single-arm support clinical communication of technical guidelines prior to marketing authorization application for oncology drug. 2020. https://www.cde.org.cn/main/news/viewInfoCommon/e303bd3deb01db072c7b37cd46195a67.
- 13.↵Center for Drug Evaluation, National Medical Products Administration. Single-arm support clinical communication of technical guidelines for oncology drug before they enter pivotal trials. 2020. https://www.cde.org.cn/main/news/viewInfoCommon/2a6d7894c0ee2aaa37fd1ca8e941cdab.
In this issue
Single-arm trials for domestic oncology drug approvals in China
Hong Zhang, Sen Liu, Chenghao Ge, Xiaozhen Liu, Yang Liu, Chen Yin, Yi Li, Jing An, Zhongtian Yan, Xiaoyuan Chen
Cancer Biology & Medicine Nov 2023, 20230360; DOI: 10.20892/j.issn.2095-3941.2023.0360
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.